PDE5A and Alzheimer disease: Our data is supported by evidence from a recent proteomic study that showed higher circulating PDE5A levels contributed to a weighted composite score, which predicted incident Alzheimer’s disease and memory deterioration in the Framingham Heart Study Offspring cohort [43].